FRIEDMAN PAUL A

CIK 00012369279 companiesWILMINGTON, DE

SEC Profile

Transactions

Companies

Filings

CIK

0001236927

Recent Transactions

50 trades

Award
Prelude Therapeutics Inc$PRLD
Director Stock Option (Right to Buy)
2026-06-09+38,000→ 38,000 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$513.11/sh−1,094→ 209,110 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$528.18/sh−575→ 191,021 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$521.98/sh−840→ 198,823 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$530.69/sh−280→ 189,884 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$514.68/sh−1,345→ 207,765 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$532.50/sh−80→ 189,804 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$518.68/sh−1,363→ 201,190 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$537.85/sh−80→ 188,284 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$536.88/sh−487→ 188,364 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$519.88/sh−846→ 200,344 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$523.00/sh−970→ 197,853 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$511.98/sh−1,480→ 210,204 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$529.76/sh−166→ 190,164 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$535.29/sh−148→ 189,324 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$526.97/sh−1,560→ 191,596 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$529.17/sh−691→ 190,330 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$539.23/sh−480→ 187,804 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$534.16/sh−332→ 189,472 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$516.84/sh−766→ 205,003 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$536.02/sh−473→ 188,851 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$521.03/sh−681→ 199,663 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2026-01-09−24,520→ 280 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$540.36/sh−600→ 187,204 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$551.24/sh−280→ 187,164 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$517.86/sh−2,450→ 202,553 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$15.80/sh+24,520→ 211,684 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$525.05/sh−2,432→ 194,222 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$545.79/sh−40→ 187,164 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$526.00/sh−1,066→ 193,156 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$515.81/sh−1,996→ 205,769 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2026-01-09−280→ 0 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$15.80/sh+280→ 187,444 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2026-01-09$524.10/sh−1,199→ 196,654 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2025-12-10−24,800→ 24,800 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-12-10$550.93/sh−4,316→ 206,080 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-12-10$547.75/sh−624→ 211,340 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-12-10$548.51/sh−535→ 210,805 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-12-10$549.99/sh−409→ 210,396 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-12-10$555.39/sh−160→ 187,164 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-12-10$551.67/sh−7,193→ 198,887 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-12-10$553.83/sh−5,001→ 188,353 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-12-10$552.74/sh−5,533→ 193,354 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-12-10$555.00/sh−1,029→ 187,324 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-12-10$15.80/sh+24,800→ 211,964 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-08-13$366.22/sh−3,152→ 296,947 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-08-13$365.19/sh−1,716→ 300,099 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-08-13$367.31/sh−7,119→ 289,828 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-08-13$371.53/sh−22,710→ 244,461 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-08-13$373.35/sh−24,166→ 191,319 total

Companies

Recent Filings

Address

C/O PRELUDE THERAPEUTICS INCORPORATED 175 INNOVATION BOULEVARD

WILMINGTON, DE, 19805

View on SEC.gov